Lingamneni Anila 4
4 · HAEMONETICS CORP · Filed May 8, 2024
Insider Transaction Report
Form 4
Lingamneni Anila
EVP, Chief Technology Officer
Transactions
- Sale
Common Stock
2024-05-06$95.00/sh−2,305$218,975→ 12,295 total
Footnotes (2)
- [F1]Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023).
- [F2]This number includes unvested restricted stock units previously reported as well as 289 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2024.